Flow Diverters Market Size Worth USD 1,596.17 Million by 2034 | CAGR: 13.4%

The global flow diverters market size is expected to reach USD 1,596.17 Million by 2034, according to a new study by Polaris Market Research. The report “Flow Diverters Market Size, Share, Trends, Industry Analysis Report: By Flow Diverter Type [Pipeline Embolization Device (PED), Flow Modulation Device (FMD), Stent-Assisted Coiling (SAC), and Others], Application, Material, Delivery System, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Flow diverters are devices used to treat brain aneurysms by redirecting blood flow away from the aneurysm. They are a minimally invasive procedure that’s typically performed under general anesthesia. The flow diverters market is experiencing significant growth, driven by increasing awareness of cerebrovascular diseases, particularly intracranial aneurysms, and the rising demand for minimally invasive treatments. Advancements in device technology, including improved materials and delivery systems, are enhancing the efficacy and safety of flow diverters, contributing to their growing adoption. Key opportunities in the market include expanding healthcare infrastructure in emerging regions, which is boosting access to advanced treatment options.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/flow-diverters-market/request-for-sample

Trends such as a shift toward non-invasive procedures and a focus on long-term patient outcomes are expected to shape the market's growth trajectory. Overall, the market is poised for continued growth, fueled by ongoing innovations, the increasing burden of cerebrovascular conditions, and the adoption of minimally invasive medical technologies.

Flow Diverters Market Key Report Highlights

• Based on flow diverter type, the pipeline embolization device (PED) segment dominates the market due to its proven effectiveness in treating complex intracranial aneurysms. At the same time, the flow modulation device (FMD) is the fastest-growing segment, driven by its emerging clinical adoption and benefits in treating vascular conditions with reduced complications.
• Based on application, the intracranial aneurysms segment holds the largest market share due to their high prevalence and the effectiveness of flow diverters in treating these conditions. The arteriovenous malformations (AVMs) segment is experiencing the fastest growth, supported by increasing clinical recognition of flow diverters’ potential in treating complex vascular malformations.
• Nitinol is the leading material segment due to its flexibility and biocompatibility, making it ideal for use in flow diverters. The cobalt-chromium alloy segment is registering the fastest growth, driven by its improved strength and visibility during procedures.
• Based on delivery system, the over-the-wire delivery system segment continues to dominate the market due to its precision and control during device deployment. At the same time, the catheter-based delivery system is the fastest-growing segment, gaining traction due to its flexibility and reduced procedure time.
• North America holds the largest market share, supported by its advanced healthcare infrastructure and high adoption rates of flow diverter technologies. Asia Pacific is the fastest growing region, driven by improvements in healthcare access and increasing awareness of cerebrovascular diseases.
• A few of the key players in the flow diverters market include Medtronic; Stryker Corporation; Johnson & Johnson (via its subsidiary, Neurovascular); Abbott Laboratories; Terumo Corporation; Boston Scientific; MicroVention (a subsidiary of Terumo); Sequent Medical (now part of Johnson & Johnson); and Penumbra, Inc. Other notable companies are Asahi Intecc, Balt Extrusion, Cook Medical, Endospan, Neuroform, and EndoMed Systems.

Polaris Market Research has segmented the flow diverters market research report on the basis of flow diverter type, application, material, delivery system, and region:

By Flow Diverter Type Outlook (Revenue–USD Million, 2020–2034)

• Pipeline Embolization Device (PED)
• Flow Modulation Device (FMD)
• Stent-Assisted Coiling (SAC)
• Others

By Application Outlook (Revenue–USD Million, 2020–2034)

• Intracranial Aneurysms
• Arteriovenous Malformations
• Carotid Artery Disease
• Others

By Material Outlook (Revenue–USD Million, 2020–2034)

• Nitinol
• Cobalt-Chromium Alloy
• Stainless Steel
• Others

By Delivery System Outlook (Revenue–USD Million, 2020–2034)

• Over-the-Wire Delivery System
• Catheter-Based Delivery System
• Others

By Regional Outlook (Revenue–USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  •  Japan
  •  India
  •  Malaysia
  •  South Korea
  • Indonesia
  • Australia
  • Vietnam
  •  Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Flow Diverters Market Report Scope